260 related articles for article (PubMed ID: 18665374)
1. Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.
Zhu XL; Liang L; Ding YQ
Int J Colorectal Dis; 2008 Nov; 23(11):1041-7. PubMed ID: 18665374
[TBL] [Abstract][Full Text] [Related]
2. [Expression of FMNL2 and its relation to the metastatic potential of human colorectal cancer cells].
Zhu XL; Liang L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1775-8. PubMed ID: 18971169
[TBL] [Abstract][Full Text] [Related]
3. FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer.
Yang SS; Li XM; Yang M; Ren XL; Hu JL; Zhu XH; Wang FF; Zeng ZC; Li JY; Cheng ZQ; Liao WT; Ding YQ; Guan J; Liang L
Br J Cancer; 2017 Oct; 117(8):1164-1175. PubMed ID: 28817833
[TBL] [Abstract][Full Text] [Related]
4. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.
Zhu XL; Zeng YF; Guan J; Li YF; Deng YJ; Bian XW; Ding YQ; Liang L
J Pathol; 2011 Jul; 224(3):377-88. PubMed ID: 21506128
[TBL] [Abstract][Full Text] [Related]
5. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
6. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
7. CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal.
Yan Y; Su M; Qin B
Biochem Biophys Res Commun; 2020 Apr; 524(4):839-846. PubMed ID: 32046858
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
9. A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC.
Yan Y; Wang Z; Qin B
Biochem Biophys Res Commun; 2019 Feb; 509(2):441-447. PubMed ID: 30594388
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
11. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.
Ren XL; He GY; Li XM; Men H; Yi LZ; Lu GF; Xin SN; Wu PX; Li YL; Liao WT; Ding YQ; Liang L
J Cancer Res Clin Oncol; 2016 Mar; 142(3):581-92. PubMed ID: 26515696
[TBL] [Abstract][Full Text] [Related]
13. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
[TBL] [Abstract][Full Text] [Related]
14. A specific FMNL2 isoform is up-regulated in invasive cells.
Péladeau C; Heibein A; Maltez MT; Copeland SJ; Copeland JW
BMC Cell Biol; 2016 Aug; 17(1):32. PubMed ID: 27578625
[TBL] [Abstract][Full Text] [Related]
15. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
16. LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis.
Shao HJ; Li Q; Shi T; Zhang GZ; Shao F
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3749-3759. PubMed ID: 31115001
[TBL] [Abstract][Full Text] [Related]
17. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
18. Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation.
Ren XL; Qiao YD; Li JY; Li XM; Zhang D; Zhang XJ; Zhu XH; Zhou WJ; Shi J; Wang W; Liao WT; Ding YQ; Liang L
Cancer Lett; 2018 Apr; 419():245-256. PubMed ID: 29374558
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.
Yuan K; Xie K; Fox J; Zeng H; Gao H; Huang C; Wu M
Gastroenterology; 2013 Oct; 145(4):853-64.e9. PubMed ID: 23770133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
